Callos Andrew's Form 4 filing
Cytokinetics Inc (CYTK) · filed Mar 18, 2026
- Accession no.
- 0001061983-26-000028
- Filed
- Mar 18, 2026
- Trade date
- Mar 17, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $530.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Callos AndrewCIK 0001852129 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | SSaleDisposed | −5,626 | $62.15 | −$349,655.9 | 74,489 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −2,916 | $62.15 | −$181,229.4 | 71,573 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.